| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $110.43 | $25.44 | 334.07% | 208.36x | 52.56x | 14.01x | 16.91x | 1.51x | $106.92M | 0.92% | $705.78M | 6.70 | $11.84B | 1,508.69 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $23.85 | $8.65 | 175.63% | 113.57x | 55.47x | 6.71x | 13.59x | 0.98x | $39.15M | 1.26% | $220.58M | 1.69 | $3.08B | 67.79 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $267.40 | $83.91 | 218.69% | 43.84x | 39.42x | 7.44x | 26.42x | 1.55x | $793.95M | 2.22% | $1.35B | 10.14 | $37.06B | 31.42 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $79.89 | $18.33 | 335.88% | 74.66x | 68.35x | 7.37x | 9.53x | 1.91x | $182.84M | 2.95% | $654.15M | 8.43 | $6.07B | 50.57 | ||
| HALO | HALOZYME THERAPEUTICS INC | $109.66 | $71.85 | 52.63% | 30.80x | 12.14x | 7.73x | 86.71x | 0.63x | $806.22M | 6.27% | $143.54M | 1.22 | $14.43B | 20.08 | ||
| RPRX | ROYALTY PHARMA PLC | $63.11 | $38.11 | 65.61% | 33.57x | 11.78x | 11.08x | 3.71x | 0.68x | $2.92B | 10.41% | $9.79B | 21.99 | $44.44B | 37.79 | ||
| KRYS | KRYSTAL BIOTECH INC | $369.23 | $89.20 | 313.94% | 44.65x | 47.30x | 24.75x | 8.04x | 2.37x | $257.78M | 2.36% | $1.36B | 46.03 | $10.51B | 45.05 | ||
| VCEL | VERICEL CORP | $40.89 | $8.46 | 383.30% | 85.19x | 73.06x | 6.82x | 5.66x | 2.09x | $61.66M | 2.95% | $370.04M | 7.25 | $2.06B | 46.79 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.30 | $8.05 | 52.71% | 12.95x | 11.31x | 5.35x | 3.36x | 1.13x | $82.01M | 11.27% | $217.65M | 3.68 | $586.60M | 7.59 | ||
| TECH | BIO-TECHNE CORP | $72.30 | $17.34 | 316.98% | 61.79x | 34.63x | 9.28x | 5.38x | 1.95x | $263.22M | 2.33% | $2.11B | 13.52 | $11.36B | 32.68 | ||
| TGTX | TG THERAPEUTICS INC | $56.90 | $23.73 | 139.83% | 18.47x | 57.25x | 10.09x | 14.42x | 2.06x | $17.39M | 0.22% | $604.08M | 4.26 | $8.98B | 64.49 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $66.97 | $19.93 | 235.99% | 176.24x | 23.00x | 3.80x | 2.05x | 1.16x | $738.18M | 5.70% | $6.32B | 32.68 | $16.28B | 42.20 | ||
| ADMA | ADMA BIOLOGICS INC | $9.51 | $7.38 | 28.79% | 13.21x | 11.95x | 4.24x | 5.22x | 0.77x | $116.47M | 5.36% | $408.21M | 1.79 | $2.19B | 9.41 | ||
| EXEL | EXELIXIS INC | $58.53 | $31.71 | 84.59% | 17.79x | 17.72x | 6.03x | 7.87x | 1.17x | $1.17B | 7.99% | $1.84B | 7.35 | $14.39B | 13.23 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $286.92 | $90.94 | 215.49% | 28.49x | 30.37x | 19.81x | 5.91x | 2.15x | $130.62M | 2.27% | $967.52M | 48.22 | $5.84B | 20.95 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $245.57 | $188.37 | 30.37% | 16.09x | 9.61x | 3.37x | 3.32x | 0.68x | $1.62B | 10.43% | $4.80B | 75.98 | $18.72B | 11.58 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.22 | $6.29 | -80.60% | 8.71x | -4.12x | 1.50x | 1.61x | 0.07x | $19.58M | 27.70% | $44.20M | 0.76 | $22.32M | 2.92 | ||
| MDXG | MIMEDX GROUP INC | $4.55 | $1.51 | 201.64% | 113.75x | -32.43x | 1.89x | 3.07x | 1.08x | $44.50M | 6.62% | $216.00M | 1.46 | $544.58M | 23.88 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $556.75 | $161.05 | 245.71% | 32.13x | 28.96x | 11.22x | 6.97x | 2.28x | $3.80B | 2.69% | $20.25B | 79.81 | $136.95B | 24.89 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $852.03 | $451.43 | 88.74% | 20.32x | 15.27x | 5.64x | 2.77x | 1.08x | $3.76B | 4.29% | $31.71B | 308.48 | $87.97B | 15.30 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $42.86 | $31.85 | 34.58% | 13.65x | 10.28x | 2.59x | 2.50x | 0.81x | $354.90M | 14.29% | $999.24M | 17.25 | $2.10B | 7.50 | ||
| UTHR | UNITED THERAPEUTICS CORP | $492.02 | $202.74 | 142.69% | 16.27x | 18.37x | 6.64x | 3.30x | 2.81x | $1.09B | 5.21% | $6.40B | 150.24 | $19.30B | 11.51 | ||
| INCY | INCYTE CORP | $128.83 | $62.34 | 106.65% | 15.87x | 36.34x | 4.44x | 4.12x | 1.78x | $1.92B | 7.44% | $6.34B | 31.66 | $22.16B | 10.72 | ||
| VCYT | VERACYTE INC | $44.88 | $7.17 | 526.28% | 31.17x | 42.93x | 6.39x | 2.60x | 123.97x | $165.99M | 4.63% | $1.39B | 17.36 | $3.35B | 23.96 |